Epigenetics-targeted drugs: current paradigms and future challenges
Open accessThe DOI matches its Crossref record; 1,077 of the 1,077 references it cites were found in a registry or an index.
Abstract
Epigenetics governs a chromatin state regulatory system through five key mechanisms: DNA modification, histone modification, RNA modification, chromatin remodeling, and non-coding RNA regulation. These mechanisms and their associated enzymes convey genetic information independently of DNA base sequences, playing essential roles in organismal development and homeostasis. Conversely, disruptions in epigenetic landscapes critically influence the pathogenesis of various human diseases. This understanding has laid a robust theoretical groundwork for developing drugs that target epigenetics-modifying enzymes in pathological conditions. Over the past two decades, a growing array of small molecule drugs targeting epigenetic enzymes such as DNA methyltransferase, histone deacetylase, isocitrate dehydrogenase, and enhancer of zeste homolog 2, have been thoroughly investigated and implemented as therapeutic options, particularly in oncology. Additionally, numerous epigenetics-targeted drugs are undergoing clinical trials, offering promising prospects for clinical benefits. This review delineates the roles of epigenetics in physiological and pathological contexts and underscores pioneering studies on the discovery and clinical implementation of epigenetics-targeted drugs. These include inhibitors, agonists, degraders, and multitarget agents, aiming to identify practical challenges and promising avenues for future research. Ultimately, this review aims to deepen the understanding of epigenetics-oriented therapeutic strategies and their further application in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 801–1,000 of 1,077
Schiedel, M., Lehotzky, A., Szunyogh, S., Oláh, J., Hammelmann, S., Wössner, N., Robaa, D., Einsle, O., Sippl, W., Ovádi, J., et al. (2020) · ChemBioChem · doi:10.1002/cbic.202000351 · Cited by 31
Design, Synthesis, and Biological Evaluation of Lysine Demethylase 5 C Degraders
Iida, T., Itoh, Y., Takahashi, Y., Yamashita, Y., Kurohara, T., Miyake, Y., Oba, M., & Suzuki, T. (2021) · ChemMedChem · doi:10.1002/cmdc.202000933 · Cited by 31
The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington’s Disease Mice
Hecklau, K., Mueller, S. G., Koch, S., Mehkary, M., Kilic, B., Harms, C., Boehm‐Sturm, P., & Yildirim, F. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.616886 · Cited by 31
Mehta–Shah, N., Lunning, M. A., Moskowitz, A. J., Boruchov, A. M., Ruan, J., Lynch, P., Hamlin, P. A., Leonard, J. P., Matasar, M. J., Myskowski, P. L., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26288 · Cited by 31
Haque, T. Z., Cadenas, F. L., Xicoy, B., Piérola, A. A., Platzbecker, U., Avivi, I. M., Brunner, A. M., Chromik, J., Morillo, D., Patel, M. R., et al. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107390 · Cited by 31
Tong, C., Chang, X., Qu, F., Bian, J., Wang, J., Li, Z., & Xu, X. J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116212 · Cited by 31
Meng, M., Zhong, Z., Song, L., Zhang, Z., Yin, X., Xie, X., Tian, L., Wu, W., Yang, Y., Deng, Y., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0339 · Cited by 31
ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
Thapa, R., Moglad, E. H. O., Afzal, M., Gupta, G., Bhat, A. A., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Pant, K., Ali, H., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102327 · Cited by 31
Wang, L., Bitar, M., Lu, X. M., Jacquelin, S., Nair, S., Sivakumaran, H., Hillman, K. M., Kaufmann, S., Ziegman, R., Casciello, F., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02021-y · Cited by 31
Ljubenkov, P. A., Edwards, L., Iaccarino, L., La Joie, R., Rojas, J. C., Koestler, M., Harris, B., Boeve, B. F., Borroni, B., van Swieten, J. C., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25584 · Cited by 30
2´-deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2´-deoxy-5-azacytidine
Matoušová, M., Votruba, I., Otmar, M., Tloušťová, E., Günterová, J., & Mertlíková‐Kaiserová, H. (2011) · Epigenetics · doi:10.4161/epi.6.6.16215 · Cited by 30
Qiao, J., Chen, Y., Mi, Y., Jin, H., Wang, L., Huang, T., Li, H., Song, Y., Cao, J., Wu, B., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114126 · Cited by 30
Wang, X., Kutschat, A. P., Yamada, M., Prokakis, E., Böttcher, P., Tanaka, K., Doki, Y., Hamdan, F. H., & Johnsen, S. A. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00751-w · Cited by 30
Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
Abdullah, O., Omran, Z., Hosawi, S. B. I., Hamiche, A., Bronner, C., & Alhosin, M. (2021) · Genes · doi:10.3390/genes12050622 · Cited by 30
Yin, W., Arkilo, D., Khudyakov, P., Hazel, J., Gupta, S., Quinton, M. S., Lin, J., Hartman, D. S., Bednar, M. M., Rosen, L. B., et al. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14912 · Cited by 30
Schwartz, G. G., Nicholls, S. J., Toth, P. P., Sweeney, M., Halliday, C., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar‐Zadeh, K., Ginsberg, H. N., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01311-9 · Cited by 30
Weirath, N. A., Hurben, A. K., Chao, C., Pujari, S. S., Cheng, T., Liu, S., & Tretyakova, N. Y. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00677 · Cited by 30
Self-citationSolta, A., Boettiger, K., Kovács, I., Lang, C., Megyesfalvi, Z., Ferk, F., Mišík, M., Höetzenecker, K., Aigner, C., Kowol, C. R., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1795 · Cited by 30
Woods, A. C., Norsworthy, K. J., Wang, X., Vallejo, J. J., Chow, E. C. Y., Li, R., Sun, J., Charlab, R., Jiang, X., Pazdur, R., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2234 · Cited by 30
Strachowska, M., & Robaszkiewicz, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108636 · Cited by 30
Bharti, R., Dey, G., Khan, D., Myers, A., Huffman, O. G., Saygin, C., Braley, C., Richards, E. G., Sangwan, N., Willard, B. B., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02028-5 · Cited by 30
Souza, N. H. C., Marcondes, P., Albertini, R., Mesquita‐Ferrari, R. A., Fernandes, K. P. S., & Aimbire, F. (2014) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.12.010 · Cited by 29
Dimicoli, S., Jabbour, E. J., Borthakur, G. M., Kadia, T. M., Estrov, Z. E., Yang, H., Kelly, M. A., Pierce, S. A., Kantarjian, H. M., & Garcia‐Manero, G. (2011) · American Journal of Hematology · doi:10.1002/ajh.22198 · Cited by 29
Bever, K. M., Thomas, D. L., Zhang, J., Rivera, E. A. D., Rosner, G. L., Zhu, Q., Nauroth, J. M., Christmas, B. J., Thompson, E. D., Anders, R. A., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01014-8 · Cited by 29
Development of potent dimeric inhibitors of GAS41 YEATS domain
Listunov, D., Linhares, B. M., Kim, E., Winkler, A., Simes, M. L., Weaver, S., Cho, H. J., Rizo, A. N., Zolov, S. N., Keshamouni, V. G., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.06.010 · Cited by 29
DNA Methylation in Huntington’s Disease
Zsindely, N., Siági, F., & Bodai, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312736 · Cited by 29
Xu, K. M., Ramesh, K. K., Huang, V., Gurbani, S. S., Cordova, J. S., Schreibmann, E., Weinberg, B. D., Sengupta, S., Voloschin, A. D., Holdhoff, M., et al. (2022) · Tomography · doi:10.3390/tomography8020057 · Cited by 29
Mascarenhas, J. O., Marcellino, B. K., Lü, M., Kremyanskaya, M., Fabris, F., Sandy, L., Mehrotra, M., Houldsworth, J., Najfeld, V., Jamal, S. M. E., et al. (2019) · Leukemia Research · doi:10.1016/j.leukres.2019.106272 · Cited by 29
Taylor, A. M., Bailey, C., Belmont, L. D., Campbell, R., Cantone, N. R., Côté, A., Crawford, T. D., Cummings, R. T., DeMent, K., Duplessis, M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00662 · Cited by 29
Fortin, J., Chiang, M.-F., Meydan, C., Foox, J., Ramachandran, P., Leca, J., Lemonnier, F., Li, W. Y., Gams, M. S., Sakamoto, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208176120 · Cited by 29
Extracellular vesicles improve GABAergic transmission in Huntington's disease iPSC-derived neurons
Beatriz, M., Rodrigues, R. J., Vilaça, R., Egas, C., Pinheiro, P. S., Daley, G. Q., Schlaeger, T. M., Raimundo, N., Rego, A. C., & Lopes, C. (2023) · Theranostics · doi:10.7150/thno.81981 · Cited by 29
Shah, R., Spektor, T. M., Weisenberger, D. J., Ding, H., Patil, R., Amador, C., Song, X.-Y., Chun, S. T., Inzalaco, J., Turjman, S., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05960-1 · Cited by 29
Wang, Z., Yin, L., Xiong, Z., Huang, F., Yang, N., Jiang, F., Li, H., Cui, Y., Ren, J., Cheng, Z., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01028 · Cited by 29
Emerging Roles for DNA 6mA and RNA m6A Methylation in Mammalian Genome
Xie, L., Zhang, X., Xie, J., Xu, Y., Li, X., & Li, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813897 · Cited by 29
Cai, S. F., Huang, Y., Lance, J. R., Mao, H. C., Dunbar, A. J., McNulty, S. N., Druley, T. E., Li, Y., Baer, M. R., Stock, W., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023010563 · Cited by 29
Bewersdorf, J. P., Shallis, R. M., Sharon, E., Park, S., Ramaswamy, R., Roe, C. E., Irish, J. M., Caldwell, A. B., Wei, W., Yacoub, A., et al. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05552-4 · Cited by 29
Ferrarotto, R., Swiecicki, P. L., Zandberg, D. P., Baiocchi, R. A., Wesolowski, R., Rodriguez, C. P., McKean, M. A., Kang, H., Monga, V., Nath, R., et al. (2023) · Oral Oncology · doi:10.1016/j.oraloncology.2023.106634 · Cited by 29
EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors
Al‐Hasani, K., Marikar, S. N., Kaipananickal, H., Maxwell, S., Okabe, J., Khurana, I., Karagiannis, T., Liang, J. J., Mariana, L., Loudovaris, T., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01707-x · Cited by 29
Dhulkifle, H., Diab, M., Algonaiah, M. A., Korashy, H. M., & Maayah, Z. H. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00219 · Cited by 29
The pharmacoepigenetic paradigm in cancer treatment
Ocaña-Paredes, B., Rivera-Orellana, S., Ramírez-Sánchez, D., Montalvo-Guerrero, J., Freire, M. P., Espinoza-Ferrao, S., Altamirano-Colina, A., Echeverría-Espinoza, P., Ramos-Medina, M. J., Echeverría‐Garcés, G., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1381168 · Cited by 29
Bauer, K., Hauswirth, A. W., Gleixner, K. V., Greiner, G., Thaler, J., Bettelheim, P., Filik, Y., Koller, E., Hoermann, G., Staber, P. B., et al. (2024) · American Journal of Hematology · doi:10.1002/ajh.27385 · Cited by 29
Walewski, J. A., Paszkiewicz‐Kozik, E., Borsaru, G., Hellmann, A. R., Janíková, A., Warszewska, A., Mais, A., Ammendola, A., Herz, T., Krauss, B., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1492122 · Cited by 28
Chen, H., Chen, Y.-Z., Wang, C.-H., & Lin, F. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108319 · Cited by 28
Georgel, P. T., & Georgel, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.752359 · Cited by 28
Tang, K., Jiao, L.-M., Qi, Y., Wang, T., Li, Y., Xu, J., Wang, Z., Yu, B., Liu, H., & Zhao, W. H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00797 · Cited by 28
Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation
Peng, Y., Tang, R., Ding, L., Zheng, R., Liu, Y., Yin, L., Fu, Y., Deng, T., & Li, X. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175522 · Cited by 28
Johnson, M. L., Strauss, J. F., Patel, M. R., Garon, E. B., Eaton, K. D., Neskorik, T., Morin, J., Chao, R. C., & Halmos, B. (2023) · Clinical Lung Cancer · doi:10.1016/j.cllc.2023.01.013 · Cited by 28
Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting
DiNardo, K. W., LeBlanc, T. W., & Chen, H. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01411-x · Cited by 28
Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease
Ortega, M. A., León-Oliva, D. D., Montero, C. G., Fraile‐Μartinez, O., Boaru, D. L., Toledo-Lobo, M. V., García‐Tuñón, I., Royuela, M., García‐Honduvilla, N., Buján, J., et al. (2023) · Genes · doi:10.3390/genes14040915 · Cited by 28
Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC
Liu, J., Lin, W., Su, W., Wu, Z., Yang, Q., Wang, S., Sun, T.-G., Huang, C., Wang, X., & Sun, Z. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110243 · Cited by 28
A Degron Blocking Strategy Towards Improved CRL4 CRBN Recruiting PROTAC Selectivity**
Bouguenina, H., Scarpino, A., O’Hanlon, J. A., Warne, J. M., Wang, H., Hak, L. C. W., Sadok, A., McAndrew, C., Stubbs, M., Pierrat, O. A., et al. (2023) · ChemBioChem · doi:10.1002/cbic.202300351 · Cited by 28
Blood DNA methylation signature of diet quality and association with cardiometabolic traits
Domínguez-Barragán, J., Fernández‐Sanlés, A., Hernáez, Á., Llauradó-Pont, J., Marrugat, J., Robinson, O., Tzoulaki, I., Elosúa, R., & Lassale, C. M. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad317 · Cited by 28
Hu, J., Duan, H., Zou, J., Ding, W., Wei, Z., Peng, Q., Li, Z., Duan, R., Sun, J., & Zhu, J. (2024) · Aging · doi:10.18632/aging.205369 · Cited by 28
Bataller, Á., Bravo, G. M., Bazinet, A., Alvarado, Y., Chien, K. S., Venugopal, S., Ishizawa, J., Hammond, D. E., Swaminathan, M., Sasaki, K., et al. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00367-8 · Cited by 28
Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats
Kundu, A., Richa, S., Dey, P., Kim, K. S., Son, J. Y., Kim, H. R., Lee, S.-Y., Lee, B.-H., Lee, K. Y., Kacew, S., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114899 · Cited by 27
A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosis
Bose, P., Swaminathan, M., Pemmaraju, N., Ferrajoli, A., Jabbour, E. J., Daver, N. G., Dinardo, C. D., Alvarado, Y., Yilmaz, M. E., Huynh-Lu, J., et al. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1543876 · Cited by 27
Ghazy, E., Zeyen, P., Herp, D., Hügle, M., Schmidtkunz, K., Erdmann, F., Robaa, D., Schmidt, M., Morales, E., Romier, C., et al. (2020) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2020.112338 · Cited by 27
Collier, K. A., Valencia, H. E., Newton, H. B., Hade, E. M., Sborov, D. W., Cavaliere, R., Poi, M. J., Phelps, M. A., Liva, S. G., Coss, C. C., et al. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04229-3 · Cited by 27
Kim, S., Lee, E. S., Lee, E. J., Jung, J. Y., Lee, S. B., Lee, H. J., Kim, J., Kim, H. J., Lee, J. W., Son, B. H., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01839-4 · Cited by 27
Role of NSD1 as potential therapeutic target in tumor
Yang, C., Wang, K., Liang, Q., Tian, T., & Zhong, Z. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105888 · Cited by 27
Jo, J. H., Jung, D., Lee, H. S., Park, S. B., Chung, M. J., Park, J. Y., Bang, S., Park, S. W., Cho, S., & Song, S. Y. (2022) · International Journal of Cancer · doi:10.1002/ijc.34144 · Cited by 27
O'Connell, C. L., Baer, M. R., Ørskov, A. D., Saini, S. K., Duong, V. H., Kropf, P. L., Hansen, J. W., Tsao-Wei, D. D., Jang, H. J., Emadi, A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1810 · Cited by 27
Ligon, J. A., Sundby, R. T., Wedekind, M. F., Arnaldez, F. I., Rivero, J. D., Wiener, L. S., Srinivasan, R., Spencer, M., Carbonell, A., Lei, H., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2168 · Cited by 27
AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer
Fu, Y., Cao, T., Zou, X., Ye, Y., Liu, Y., Peng, Y., Deng, T., Yin, L., & Li, X. (2023) · Oncogenesis · doi:10.1038/s41389-022-00446-y · Cited by 27
Acan downregulation in parvalbumin GABAergic cells reduces spontaneous recovery of fear memories
Lavertu-Jolin, M., Chattopadhyaya, B., Chehrazi, P., Carrier, D., Wünnemann, F., Leclerc, S., Dumouchel, F., Robertson, D. N., Affia, H., Saba, K., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02085-0 · Cited by 27
Zhang, J., Yang, T., Han, M., Wang, X., Yang, W., Guo, N., Ren, Y., Cui, W., Li, S., Zhao, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adc9273 · Cited by 27
Bauer, N., Balourdas, D.-I., Schneider, J. R., Zhang, X., Berger, L. M., Berger, B., Schwalm, M. P., Klopp, N., Siveke, J. T., Knapp, S., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00427 · Cited by 27
Gómez‐Pinilla, F., & Thapak, P. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.04.237 · Cited by 27
Malone, C. F., Mabe, N. W., Forman, A. B., Alexe, G., Engel, K. L., Chen, Y.-J. C., Soeung, M., Salhotra, S., Thayakumar, A., Liu, B., et al. (2024) · Science Advances · doi:10.1126/sciadv.adm9449 · Cited by 27
Kagiyama, Y., Fujita, S., Shima, Y., Yamagata, K., Katsumoto, T., Nakagawa, M., Honma, D., Adachi, N., Araki, K., Kato, A., et al. (2021) · Cancer Science · doi:10.1111/cas.14905 · Cited by 26
Spinck, M., Bischoff, M., Lampe, P., Meyer‐Almes, F., Sievers, S., & Neumann, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00017 · Cited by 26
Cummings, J. L., Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210570 · Cited by 26
Liu, W. H., Miner, R. E., Albaugh, B. N., Ananiev, G. E., Wildman, S. A., & Denu, J. M. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00698 · Cited by 26
Yang, L., Chen, X., Lee, C., Shi, J., Lawrence, E. B., Zhang, L., Li, Y., Gao, N., Jung, S. Y., Creighton, C. J., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02689-y · Cited by 26
Wang, D., Long, J., Li, R., Zhang, D.-L., Liu, H., Liu, J., Tian, J.-C., Liu, J., Liu, J., Zhao, H., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01930-8 · Cited by 26
Self-citationChemical inhibitors targeting histone methylation readers
Huang, X., Chen, Y., Xiao, Q., Shang, X., & Liu, Y. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108614 · Cited by 26
Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease
González-Latapí, P., Bustos, B. I., Dong, S., Lubbe, S. J., Simuni, T., & Krainc, D. (2024) · Annals of Neurology · doi:10.1002/ana.26923 · Cited by 26
Stulemeijer, I. J. E., Vos, D. E. D., van Harten, K., Joshi, O., Blomberg, O. S., van Welsem, T., Terweij, M., Vlaming, H., de Graaf, E. L., Altelaar, M. A. F., et al. (2015) · Scientific Reports · doi:10.1038/srep09824 · Cited by 25
Shim, K.-H., Kim, S.-H., Hur, J., Kim, D., Demirev, A. V., & Yoon, S. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104519 · Cited by 25
Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells
Yeung, B. H. Y., Huang, J., An, S. S., Solway, J., Mitzner, W., & Tang, W. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0323oc · Cited by 25
Ravandi, F., Roboz, G. J., Wei, A. H., Döhner, H., Pocock, C., Selleslag, D., Montesinos, P., Sayar, H., Musso, M., Álvarez, Á. F., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01142-x · Cited by 25
Kori, S., Shibahashi, Y., Ekimoto, T., Nishiyama, A., Yoshimi, S., Yamaguchi, K., Nagatoishi, S., Ohta, M., Tsumoto, K., Nakanishi, M., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116500 · Cited by 25
Masuda, N., Tamura, K., Yasojima, H., Shimomura, A., Sawaki, M., Lee, M.-J., Yuno, A., Trepel, J. B., Kimura, R., Nishimura, Y., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08973-4 · Cited by 25
Wang, J., Xia, W., Xian, Y.-E., Chen, Z., Sun, Y., Fu, Y., Wu, Z., Li, P.-X., Zhou, E., & Yang, Z. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102017 · Cited by 25
Hung, P., Hsu, Y., Chen, T., Ho, C., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169407 · Cited by 25
Deng, Q., Li, H., Yue, X., Guo, C., Sun, Y., Ma, C., Gao, J., Wu, Y., Du, B., Yang, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06054-x · Cited by 25
Androgen Receptor–Interacting Proteins in Prostate Cancer Development and Therapy Resistance
Čulig, Z., & Puhr, M. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.12.003 · Cited by 25
Hao, B., Ma, K., Xu, J.-Y., Fan, R., Zhao, W.-S., Jia, X., Zhai, L., Lee, S., Xie, D., & Tan, M. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01236-5 · Cited by 25
Wang, J., Zhang, Y., Gao, J., Feng, G., Liu, C., Li, X., Li, P., Liu, Z., Lu, F., Wang, L., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01292-9 · Cited by 25
Jiang, Z., Cai, G., Liu, H., Liu, L., Huang, R., Nie, X., Gui, R., Li, J., Ma, J., Cao, K., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02525-1 · Cited by 25
Zhang, Y., Fong, K.-W., Mao, F., Wang, R., Allison, D. B., Napier, D. L., He, D., Liu, J., Zhang, Y., Chen, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114431 · Cited by 25
Hügle, M. J., Regenass, P., Warstat, R., Hau, M., Schmidtkunz, K., Lucas, X., Wohlwend, D., Einsle, O., Jung, M., Breit, B., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00478 · Cited by 24
Emerging drugs for the treatment of cutaneous T-cell lymphoma
Cheng, M., Zain, J. M., Rosen, S. T., & Querfeld, C. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2049233 · Cited by 24
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening
Shishodia, S., Nuñez, R., Strohmier, B. P., Bursch, K. L., Goetz, C. J., Olp, M. D., Jensen, D. R., Fenske, T. G., Ordonez‐Rubiano, S. C., Blau, M. E., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00864 · Cited by 24
Shafer, D. A., Kagan, A. B., Rudek, M. A., Kmieciak, M., Tombes, M. B., Shrader, E., Bandyopadhyay, D., Hudson, D., Sankala, H. M., Weir-Wiggins, C., et al. (2023) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-023-04511-0 · Cited by 24
Atypical histone targets of PHD fingers
Black, J. C., & Kutateladze, T. G. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104601 · Cited by 24
Jolly, A., Lu, S., Dubner, A., Strand, K. A., Mutryn, M. F., Pilotti-Riley, A., Danis, E. P., Nemenoff, R. A., Moulton, K. S., Majesky, M. W., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.164862 · Cited by 24
Li, F., Yu, J., Pan, T., Feng, H., Li, J., Yu, B., Fan, Z., Sang, Q., Chen, M., Zang, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202303091 · Cited by 24
Cescon, D. W., Hilton, J. F., Morales, S. M., Layman, R. M., Pluard, T., Yeo, B. J., Park, I. H., Provencher, L., Kim, S., Im, Y., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0133 · Cited by 24
Fischetti, I., Botti, L., Sulsenti, R., Cancila, V., Enriquez, C., Ferri, R., Bregni, M., Crivelli, F., Tripodo, C., Colombo, M. P., et al. (2024) · Epigenomics · doi:10.2217/epi-2023-0374 · Cited by 24
Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome
Tsang, E., Han, V. X., Flutter, C., Alshammery, S., Keating, B. A., Williams, T. A., Gloss, B., Graham, M. E., Aryamanesh, N., Pang, C. N. I., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105156 · Cited by 24
Lin, J., Elkon, J. M., Ricart, B., Palmer, E., Delgado, C. Z., Noonepalle, S. K. R., Burgess, B., Siegel, R., Ma, Y., & Villagra, A. (2021) · The Oncologist · doi:10.1002/onco.13957 · Cited by 23
Yu, X., Xu, X., Dong, W., Yang, C., Luo, Y., He, Y., Jiang, C., Wu, Y., & Wang, J. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119265 · Cited by 23
Structure of DNMT3B homo-oligomer reveals vulnerability to impairment by ICF mutations
Gao, L., Guo, Y., Biswal, M. N., Lu, J., Yin, J., Fang, J., Chen, X., Shao, Z., Huang, M., Wang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31933-w · Cited by 23
Kong, X., Yan, K. H., Deng, P., Fu, H., Sun, H., Huang, W., Jiang, S., Dai, J., Zhang, Q. C., Liu, J., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac780 · Cited by 23
Regulation of serine palmitoyl-transferase and Rac1–Nox2 signaling in diabetic retinopathy
Alka, K., Mohammad, G., & Kowluru, R. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-20243-2 · Cited by 23
Zhou, J., Wu, X., Zhang, H., Wang, X., Yuan, Y., Zhang, S., Jiang, Z., & Wang, T. (2022) · The Breast · doi:10.1016/j.breast.2022.10.018 · Cited by 23
A small-molecule degrader of TET3 as treatment for anorexia nervosa in an animal model
Lv, H., Catarino, J. D. S., Li, D., Liu, B., Gao, X., Horváth, T. L., & Huang, Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300015120 · Cited by 23
Self-citationZhou, S. M., Ou, H., Wu, Y., Qi, D., Pei, X., Yu, X., Hu, X., & Wu, E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108434 · Cited by 23
Xu, X., Zhang, Q., Wang, X., Jin, J., Wu, C., Li, F., Yang, X., Zhao, M., Chen, Y., Lu, S., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.014 · Cited by 23
Han, Y., Sun, K., Yu, S., Qin, Y., Zhang, Z., Luo, J., Hu, H., Dai, L., Cui, M., Jiang, C., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00082-9 · Cited by 23
Increased PTCHD4 expression via m6A modification of PTCHD4 mRNA promotes senescent cell survival
Rossi, M. S., Banskota, N., Shin, C. H., Anerillas, C., Tsitsipatis, D., Yang, J., Munk, R. B., Martindale, J. L., Yang, X., Piao, Y., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae322 · Cited by 23
Watanabe, J., Clutter, M. R., Gullette, M. J., Sasaki, T., Uchida, E., Kaur, S., Mo, Y., Abe, K., Ishi, Y., Takata, N., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174794 · Cited by 23
Vey, N., Prébet, T., Thalamas, C., Charbonnier, A., Rey, J., Kloos, I., Liu, E., Luan, Y., Vezan, R. N., Graef, T. T., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1263843 · Cited by 22
Takebe, N., Beumer, J. H., Kummar, S., Kiesel, B. F., Dowlati, A., Coyne, G. O., Piekarz, R., Rubinstein, L., Fogli, L. K., Vaishampayan, U. N., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14054 · Cited by 22
Liu, X., Huang, Y., Xu, L., Wu, Q., Wang, N., Zhou, L., Liu, W.-W., Ma, Q., Hu, B., Gao, H., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154289 · Cited by 22
Gilmore, S. A., Tam, D., Cheung, T. L., Snyder, C. A., Farand, J., Dick, R. A., Matles, M., Feng, J. Y., Ramírez, R., Li, L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271145 · Cited by 22
Dong, G., Zuo, J.-H., Yu, J., Xu, J., Gao, G., Li, G., Zhao, W. H., & Yu, B. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c02028 · Cited by 22
Leighton, G. O., Shang, S., Hageman, S., Ginder, G. D., & Williams, D. C. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307287120 · Cited by 22
Pereira, M. P., Herrity, E., & Kim, D. D. H. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05462-5 · Cited by 22
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
Shin, D. H., Jo, J. Y., Choi, M., Kim, K., Bae, Y., & Kim, S. S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01091-0 · Cited by 22
Rey, V., Tornín, J., Alba‐Linares, J. J., Robledo, C., Murillo, D., Rodríguez, A., Gallego, B., Huergo, C., Viera, C., Braña, A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105090 · Cited by 22
Gao, L., Lee, H. J., Goodman, J. H., & Ding, L. (2024) · Cell · doi:10.1016/j.cell.2024.03.032 · Cited by 22
Huang, M., Xie, X., Gong, P., Wei, Y., Du, H., Xu, Y., Xu, Q., Jing, Y., & Zhao, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111991 · Cited by 21
Sheikh, T. N., Chen, X., Xu, X., McGuire, J. T., Ingham, M. A., Lü, C., & Schwartz, G. K. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0066 · Cited by 21
Xiang, Q., Luo, G., Zhang, C. L., Hu, Q., Wang, C., Wu, T., Xu, H., Hu, J., Zhuang, X., Zhang, M., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114311 · Cited by 21
The role of dietary polyphenols in alternating DNA methylation in cancer
Nanakali, N. M. Q., Dana, P. M., Sadoughi, F., Asemi, Z., Sharifi, M., Asemi, R., & Yousefi, B. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2100313 · Cited by 21
Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor
Al‐Hasani, K., Khurana, I., Mariana, L., Loudovaris, T., Maxwell, S., Kaipananickal, H., Okabe, J., Cooper, M. E., & El‐Osta, A. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01034-7 · Cited by 21
JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL
Benyoucef, A., Haigh, K., Cuddihy, A. R., & Haigh, J. J. (2022) · Leukemia · doi:10.1038/s41375-022-01716-9 · Cited by 21
Chen, X., Wu, T., Du, Z., Kang, W., Xu, R., Meng, F., Liu, C., Chen, Y., Bao, Q., Shen, J., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116080 · Cited by 21
Chen, P. C., Guo, X. S., Zhang, H. E., Dubey, G. K., Geng, Z. Z., Fierke, C. A., Xu, S., Hampton, J. T., & Liu, W. R. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01419 · Cited by 21
Zhao, L., Guo, J., Xu, S., Duan, M., Liu, B., Zhao, H., Wang, Y., Liu, H., Yang, Z., Yuan, H., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.016 · Cited by 21
Röhr, D., Halfter, H., Schulz, J. B., Young, P., & Gess, B. (2017) · Glia · doi:10.1002/glia.23152 · Cited by 20
Han, L., Zhang, Y., Li, J., Xiao, Y., Lu, M. P., Li, Y., & Wang, M. (2021) · Food & Function · doi:10.1039/d1fo02577e · Cited by 20
BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
Bezrookove, V., Khan, I. A., Nosrati, M., Miller, J. R., McAllister, S. D., Dar, A. A., & Kashani–Sabet, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1011173 · Cited by 20
Issahaku, A. R., Mncube, S. M., Agoni, C., Kwofie, S. K., Alahmdi, M. I., Abo-Dya, N. E., Sidhom, P. A., Tawfeek, A. M., Ibrahim, M. A. A., Mukelabai, N., et al. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05516-5 · Cited by 20
The emerging roles of histone demethylases in cancers
Tong, D., Tang, Y., & Zhong, P. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10160-9 · Cited by 20
Chen, Y., Ying, Y., Ma, W., Ma, H., Shi, L., Gao, X., Jia, M., Li, M., Song, X., Kong, W., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1836 · Cited by 20
Li, Y., Shen, Z., Ratia, K. M., Zhao, J., Huang, F., Dubrovyskyii, O., Indukuri, D. R., Fu, J., Ramos, O. L., Thatcher, G. R. J., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01837 · Cited by 20
Yao, Y., Liu, P., Li, Y., Wang, W., Jia, H., Bai, Y., Yuan, Z., & Yang, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116171 · Cited by 20
Towards the Targeted Protein Degradation of PRMT1
Martin, P. L., Pérez-Areales, F. J., Rao, S. V., Walsh, S. J., Carroll, J. S., & Spring, D. R. (2024) · ChemMedChem · doi:10.1002/cmdc.202400269 · Cited by 20
Movahed, E., Soleimani, M., Hosseini, S., Sene, A. A., & Salehi, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28534 · Cited by 19
Baba, R., Matsuda, S., Maeda, R., Murakami, K., Yamamoto, Y., Nakatani, A., & Kimura, H. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00713 · Cited by 19
Hu, X., Zou, Y., Copland, D. A., Schewitz‐Bowers, L. P., Li, Y., Lait, P. J. P., Stimpson, M. L., Zhang, Z., Guo, S., Liang, J., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104333 · Cited by 19
Marr, A. R., Halpin, M., Corbin, D. L., Asemelash, Y., Sher, S., Gordon, B. K., Whipp, E. C., Mitchell, S. R., Harrington, B. K., Orwick, S. J., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00483-w · Cited by 19
Li, Y., Ma, B., Wang, Z., Chen, Y., & Dong, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.95316 · Cited by 19
Xuan, Y.-F., Lu, S., Ou, Y.-J., Bao, X., Huan, X., Song, S.-S., Miao, Z., & Wang, Y.-Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150011 · Cited by 19
Li, T., Cox, C. D., Ozer, B. H., Nguyen, N. T., Nguyen, H. N., Lai, T. J., Li, S., Liu, F., Kornblum, H. I., Liau, L. M., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0367 · Cited by 18
Self-citationTakemura, Y., Satoh, M., Hatanaka, K., & Kubota, S. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1459466 · Cited by 18
Gcn5-mediated acetylation at MBF-regulated promoters induces the G1/S transcriptional wave
González‐Medina, A., Hidalgo, E., & Ayté, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz561 · Cited by 18
Yalniz, F., Berdeja, J. G., Maris, M. B., Lyons, R. M., Reeves, J. A., Essell, J. H., Patel, P. A., Sekeres, M. A., Hughes, A. E., Mappa, S., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16173 · Cited by 18
Wang, J., Zhang, Q., Li, Q., Mu, Y., Jing, J., Li, W., Li, W., Wang, J., Yu, G., Wang, X., et al. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00823-4 · Cited by 18
Yuan, Y., Du, L., Tan, R., Yu, Y., Jiang, J., Yao, A., Luo, J., Tang, R., Xiao, Y., & Sun, H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00083 · Cited by 18
LncRNA LENGA acts as a tumor suppressor in gastric cancer through BRD7/TP53 signaling
Li, S., Sun, J. P., Ma, J., Zhou, C.-X., Yang, X. Y., Zhang, S., Huang, L., Jia, H., Shao, Y., Zhang, E., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04642-2 · Cited by 18
Jenner, M. W., Pawlyn, C., Davies, F. E., Menzies, T., Hockaday, A., Olivier, C., Jones, J. R., Karunanithi, K., Lindsay, J., Kishore, B., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18600 · Cited by 18
Coleman, O. D., Macdonald, J., Thomson, B., Ward, J., Stubbs, C. J., McAllister, T. E., Clark, S. M., Amin, S., Cao, Y., Abboud, M. I., et al. (2023) · Chemical Science · doi:10.1039/d2sc05944d · Cited by 18
Kikuchi, M., Takase, S., Konuma, T., Noritsugu, K., Sekine, S., Ikegami, T., Ito, A., & Umehara, T. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304103120 · Cited by 18
Zhang, M., Zhai, Y., An, X., Li, Q., Zhang, D., Zhou, Y., Zhang, S., Dai, X., & Li, Z. (2023) · Cell Proliferation · doi:10.1111/cpr.13581 · Cited by 18
Targeting systemic and gut microbial metabolism in ER+ breast cancer
Heath, H., Mogol, A. N., Casiano, A. S., Zuo, Q., & Madak‐Erdogan, Z. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.008 · Cited by 18
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma
Demir, S., Razizadeh, N., Indersie, É., Branchereau, S., Cairo, S., & Kappler, R. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000378 · Cited by 18
Mahmood, N., Arakelian, A., Szyf, M., & Rabbani, S. A. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01205-2 · Cited by 18
HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain
Manengu, C., Zhu, C., Zhang, G., Tian, M., Lan, X., Tao, L., Ma, L., Liu, Y., Yu, J., & Liu, N. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01488-x · Cited by 18
Luongo, M., Laurenziello, P., Cesta, G., Bochicchio, A. M., Omer, L. C., Falco, G., Milone, M. R., Cibarelli, F., Russi, S., & Laurino, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02083-y · Cited by 18
A Molecular Tool Targeting the Base‐Flipping Activity of Human UHRF1
Zaayter, L., Mori, M., Ahmad, T., Ashraf, W., Boudier, C., Kilin, V., Gavvala, K., Richert, L., Eiler, S., Ruff, M., et al. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201902605 · Cited by 17
Zhang, N., Shang, M., Li, H., Wu, L., Dong, M., Huang, B., Lü, J., & Zhang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073911 · Cited by 17
Yang, C., Hsu, H., Liu, Y., Tsai, W., Ma, C., Chen, Y., Tan, B. C., Lai, Y., Chang, I. Y., Yang, C., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00688-3 · Cited by 17
Guo, C., Liao, K., Li, M., Wang, I., Shaik, M. N., & Yin, D. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12882 · Cited by 17
Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins
Kim, H., Jung, I., Lee, C. H., An, J., & Ko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216375 · Cited by 17
Garcia‐Manero, G., Kaźmierczak, M., Wierzbowska, A., Fong, C. Y., Keng, M. K., Ballinari, G., Scarci, F., & Adès, L. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107480 · Cited by 17
Manda, S., Anz, B. M., Benton, C. B., Broun, E. R., Yimer, H. A., Renshaw, J. S., Geils, G. F., Berdeja, J. G., Cruz, J. C., Melear, J. M., et al. (2024) · Hematological Oncology · doi:10.1002/hon.3274 · Cited by 17
NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals
Ruan, P., Shen, J., Santella, R. M., Zhou, S., & Wang, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw546 · Cited by 16
Tambo, Y., Hosomi, Y., Sakai, H., Nogami, N., Atagi, S., Sasaki, Y., Kato, T., Takahashi, T., Seto, T., Maemondo, M., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0435-2 · Cited by 16
Thomas, D., & Majeti, R. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0270 · Cited by 16
Liu, Y., Su, C., Ko, P., Lee, R., Liu, C., Huang, Y., Gau, J., & Liu, H. (2020) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13443 · Cited by 16
Holkova, B., Shafer, D. A., Yazbeck, V. Y., Davé, S. S., Bose, P., Tombes, M. B., Shrader, E., Wan, W., Bandyopadhyay, D., Weir-Wiggins, C., et al. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1861270 · Cited by 16
KDM4 inhibitor SD49-7 attenuates leukemia stem cell via KDM4A/MDM2/p21CIP1 axis
Li, Y., Wang, C., Gao, H., Gu, J., Zhang, Y., Zhang, Y., Xie, M., Cheng, X., Yang, M. S., Zhang, W., et al. (2022) · Theranostics · doi:10.7150/thno.71460 · Cited by 16
Hazra, R., Brine, L., Garcia, L. A., Benz, B. A., Chirathivat, N., Shen, M. M., Wilkinson, J. E., Lyons, S. K., & Spector, D. L. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.10.002 · Cited by 16
Iwata, H., Nakamura, R., Masuda, N., Yamashita, T., Yamamoto, Y., Kobayashi, K., Tsurutani, J., Iwasa, T., Yonemori, K., Tamura, K., et al. (2022) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyac166 · Cited by 16
Evaluation of acyllysine isostere interactions with the aromatic pocket of the AF9 YEATS domain
Travis, C. R., Francis, D. Y., Williams, D. C., & Waters, M. L. (2022) · Protein Science · doi:10.1002/pro.4533 · Cited by 16
Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells
Ciaco, S., Mazzoleni, V., Javed, A., Eiler, S., Ruff, M., Mousli, M., Mori, M., & Mély, Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106616 · Cited by 16
Koseki, A., Araya, N., Yamagishi, M., Yamauchi, J., Yagishita, N., Takao, N., Takahashi, K., Kunitomo, Y., Honma, D., Araki, K., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1175762 · Cited by 16
Ordonez‐Rubiano, S. C., Maschinot, C. A., Wang, S., Sood, S., Baracaldo-Lancheros, L. F., Strohmier, B. P., McQuade, A. J., Smith, B. C., & Dykhuizen, E. C. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00671 · Cited by 16
Yamaji, K., Iwabuchi, S., Tokunaga, Y., Hashimoto, S., Yamane, D., Toyama, S., Kono, R., Kitab, B., Tsukiyama–Kohara, K., Osawa, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115379 · Cited by 16
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
Wu, G., Yoshida, N., Liu, J., Zhang, X., Xiong, Y., Heavican, T. B., Mandato, E., Liu, H., Nelson, G. M., Yang, L., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi7244 · Cited by 16
Ghosh, K. K., Zhou, J., Shao, J.-Y., Chen, S., & Pan, H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105597 · Cited by 16
Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL
Chow, M., Gao, L., MacManiman, J. D., Bicocca, V. T., Chang, B. H., Alumkal, J. J., & Tyner, J. W. (2018) · Oncogene · doi:10.1038/s41388-018-0299-8 · Cited by 15
MacBeth, K. J., Chopra, V. S., Tang, L., Zheng, B., Avanzino, B. C., See, W. L., Schwickart, M., Figueroa, M. E., Quek, L. S., & DiMartino, J. F. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.03.003 · Cited by 15
Leukemogenesis via aberrant self‐renewal by the MLL/AEP‐mediated transcriptional activation system
Yokoyama, A. (2021) · Cancer Science · doi:10.1111/cas.15054 · Cited by 15
Zhou, Y., Zhang, Y., Huang, H., Shen, L., Han, X., Hu, X., Yu, S., Gao, A., Sheng, L., Su, M., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00728-y · Cited by 15
He, Y., Yang, C., Wang, Y., Sacher, J. R., Sims, M. M., Pfeffer, L. M., & Miller, D. D. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116533 · Cited by 15
Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?
Qian, X., Wang, H., & Yan, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963533 · Cited by 15
Identification of nonhistone substrates of the lysine methyltransferase PRDM9
Hanquier, J. N., Sanders, K., Berryhill, C. A., Sahoo, F. K., Hudmon, A., Vilseck, J. Z., & Cornett, E. M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104651 · Cited by 15
Wright, S., Hu, J., Wang, H., Hyle, J. W., Zhang, Y., Du, G., Konopleva, M. Y., Kornblau, S. M., Djekidel, M. N., Rosikiewicz, W., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220134120 · Cited by 15
Geoerger, B., Schiff, M., Penard‐Lacronique, V., Darín, N., Saad, S.-M., Duchon, C., Lamazière, A., Desmons, A., Pontoizeau, C., Berlanga, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02382-9 · Cited by 15
Liu, S., Li, X., Li, X., & Li, X. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102334 · Cited by 15
Self-citationGentzler, R. D., Villaruz, L. C., Rhee, J. C., Horton, B. J., Mock, J., Hanley, M., Kim, K., Rudek, M. A., Phelps, M. A., Carducci, M. A., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad221 · Cited by 15
A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis
Song, N., Tang, Y., Wang, Y., Guan, X., Yu, W., Jiang, T., Lu, L., & Gu, Y. (2023) · Marine Drugs · doi:10.3390/md21100517 · Cited by 15
Fang, Y., Huang, W., Zhu, X., Wang, X., Wu, X., Wang, H., Hong, W., Yan, S., Zhang, L., Deng, Y., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42795 · Cited by 15
Self-citationGuo, J., Zou, Z., Dou, X., Zhao, X., Wang, Y., Wei, L., ., Y. P., Wang, Y., He, C., & Guo, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae093 · Cited by 15
Fbxl11 Is a Novel Negative Element of the Mammalian Circadian Clock
Reischl, S., & Kramer, A. (2015) · Journal of Biological Rhythms · doi:10.1177/0748730415587407 · Cited by 14
Cited by
Age reprogramming: Innovations and ethical considerations for prolonged longevity (Review)
Saliev, T., & Singh, P. (2025) · Biomedical Reports · doi:10.3892/br.2025.1974 · Cited by 14
Metadata
- Authors
- Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., Xiao, X., & Li, D.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-11-26
- Volume
- 9
- Issue
- 1
- Pages
- 332-332
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4404726166
- Cited by
- 339
- References
- 1,077
- FWCI
- 39.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.